To assess the effectiveness of seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) for the prevention of clinical malaria in children aged 3–59 months during the high transmission season, a cluster-randomised controlled trial (cRCT) was carried out. The trial took place in two districts of Nampula province, Mozambique, between January and April 2022.
This presentation was given at the 72nd annual meeting of the American Society of Tropical Medicine and Hygiene
Country: MozambiqueKeywords: ASTMH | Malaria | SMC | SDGs
« Back to Publications